Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.00 is 65% above its 4-year average of -2.90, near the high end of its 4-year range (-4.99–-1.00).
29.82% above its 12-month average of -1.43.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.16.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 16 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.00
EARNINGS PER SHARE (EPS) AVG TTM
-1.43
EARNINGS PER SHARE (EPS) AVG 3Y
-2.38
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+29.82%
CURRENT VS 3Y AVG
+57.89%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
NOMAD Power Solutions, Inc.
Market Cap
$52.27M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
N/A
Market Cap
$49.77M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$52.66M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.75
3Y Avg
-0.80
5Y Avg
-0.90
Market Cap
$51.61M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.75
3Y Avg
-1.03
5Y Avg
-0.90
Market Cap
$51.42M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$50.95M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$53.63M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$50.80M
Earnings Per Share (EPS)
-1.49
TTM Avg
-1.25
3Y Avg
-158.58
5Y Avg
-880.75
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $52.27M | -1.00 | -1.43 | -2.38 | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $49.77M | -8.95 | -8.42 | -12.89 | -25.33 |
| Aldeyra The (ALDX)vs › | $52.66M | -0.39 | -0.75 | -0.80 | -0.90 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.61M | -0.27 | -0.75 | -1.03 | -0.90 |
| biote Corp. (BTMD)vs › | $52.27M | 0.12 | 0.48 | 0.24 | 1.52 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -1.20 | -0.91 | -0.56 | -0.48 |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | -0.67 | -1.36 | -1.71 | -1.31 |
| ImageneBio Inc (IMA)vs › | $53.63M | -5.21 | -25.08 | -23.14 | -19.79 |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.80M | -1.49 | -1.25 | -158.58 | -880.75 |
| Clene Inc. (CLNN)vs › | $50.61M | -3.55 | -4.16 | -5.92 | -5.28 |
Trailing EPS (TTM)
$-1.00
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.26 |
| 2024-12-31 | -1.59 |
| 2023-12-31 | -2.66 |
| 2022-12-31 | -3.99 |
| 2021-12-31 | -4.99 |
